These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 939474)

  • 21. Blood pressure lowering and potassium conservation by triamterene-hydrochlorothiazide and amiloride-hydrochlorothiazide in hypertension.
    Maxwell MH; Brachfeld J; Itskovitz H; Lunn JA; Moser M; Zawada ET
    Clin Pharmacol Ther; 1985 Jan; 37(1):61-5. PubMed ID: 3880686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.
    Ramsay LE; Hettiarachchi J; Fraser R; Morton JJ
    Clin Pharmacol Ther; 1980 Apr; 27(4):533-43. PubMed ID: 7357812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of potassium supplements, spironolactone of amiloride on the potassium status of patients with heart failure.
    Davidson C; Burkinshaw L; Morgan DB
    Postgrad Med J; 1978 Jun; 54(632):405-9. PubMed ID: 683909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solute-free water retention in preascitic cirrhotic rats following intravenous water loading.
    Sansoe G; Aragno M; Smedile A; Rizzetto M; Rosina F
    J Physiol Pharmacol; 2009 Dec; 60(4):111-7. PubMed ID: 20065504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of triamterene on potassium excretion in cirrhotic patients receiving furosemide.
    Thompson EJ; Torres E; Grosberg SJ; Martinez-Maldonado M
    Clin Pharmacol Ther; 1977 Apr; 21(4):392-4. PubMed ID: 321176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The mechanism of the increase in potassium excretion produced by furosemide (author's transl)].
    Leãg MI; Helou CM; Costa R; Rocha AD; Magaldi JB
    Rev Bras Pesqui Med Biol; 1979 Dec; 12(6):391-9. PubMed ID: 542653
    [No Abstract]   [Full Text] [Related]  

  • 27. [Triamterene in the depletive treatment of cirrhosis].
    Ravenni G; Rubegni M; Forconi S
    Boll Soc Ital Biol Sper; 1964 Apr; 40(7):290-3. PubMed ID: 5875781
    [No Abstract]   [Full Text] [Related]  

  • 28. Spironolactone and amiloride in hypertensive patients with and without aldosterone excess.
    Hoefnagels WH; Drayer JI; Smals AG; Kloppenborg PW
    Clin Pharmacol Ther; 1980 Mar; 27(3):317-23. PubMed ID: 6987022
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparison of spironolactone and amiloride combined with hydrochlorothiazide in the treatment of slight or moderate hypertension].
    Sanguigni D; Benvenuti C
    Clin Ter; 1978 Oct; 87(1):69-74. PubMed ID: 737980
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diuretics in cirrhosis. Accidents. Indications].
    Andrieu J; Lesueur G
    Presse Med (1893); 1969 Mar; 77(16):575-8. PubMed ID: 5783378
    [No Abstract]   [Full Text] [Related]  

  • 31. [New clinical application of spironolactone].
    Fukuchi S
    Nihon Rinsho; 1974 Nov; 32(11):3326-32. PubMed ID: 4615183
    [No Abstract]   [Full Text] [Related]  

  • 32. [Aspects of the physiologic bioavailability of spironolactone and canrenone].
    Portal A; Gaillot J; Bieder A; Rodary C; Bertharion JJ
    Sem Hop Ther; 1976 Nov; 52(9):465-70. PubMed ID: 1006321
    [No Abstract]   [Full Text] [Related]  

  • 33. The pathophysiology of Bartter syndrome.
    Kurtzman NA; Gutierrez LF
    JAMA; 1975 Nov; 234(7):758-9. PubMed ID: 1242464
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antikaliuretic agents].
    Esch I
    Internist (Berl); 1971 Aug; 12():Suppl:352-6. PubMed ID: 4937775
    [No Abstract]   [Full Text] [Related]  

  • 35. Spironolactone and potassium canrenoate in normal man.
    Ramsay L; Shelton J; Harrison I; Tidd M; Asbury M
    Clin Pharmacol Ther; 1976 Aug; 20(2):167-77. PubMed ID: 780038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of triamterene and amiloride on urinary acidification and potassium excretion in the rat.
    Guignard JP; Peters G
    Eur J Pharmacol; 1970 May; 10(2):255-67. PubMed ID: 5446379
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical use of potassium supplements and potassium sparing diuretics.
    Morgan TO
    Drugs; 1973; 6(3):222-9. PubMed ID: 4778987
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the potassium- retaining effects of amiloride and spironolactone in hypertensive patients with thiazide-induced hypokalaemia.
    George CF; Breckenridge AM; Dollery CT
    Lancet; 1973 Dec; 2(7841):1288-91. PubMed ID: 4127641
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical evaluation of the use of diuretics in the ascitic phase of hepatic cirrhosis].
    Castagnolo B; De Colibus V; Napolitano L; Aliperta A; Caldarelli G; Abignente F
    Clin Ter; 1977 Dec; 83(6):625-9. PubMed ID: 343976
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of diuretics in preventing ascites recurrence.
    Arrigoni A; Andriulli A; Gindro T; Verme G
    Br J Clin Pract; 1988 Mar; 42(3):116-20. PubMed ID: 3207572
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.